Evidence map›Paper›PMID 31709264›Full record

ReviewFrontiers in molecular biosciences2019

RARG Gene Dysregulation in Acute Myeloid Leukemia.

Maria Rosa Conserva, Immacolata Redavid, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Francesco Albano

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in molecular biosciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The Influences of RARγ on the Behavior of Normal and Cancer Stem Cells.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Deregulation of All-International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells.International journal of molecular sciences · 2022
    Review
  14. Lessons to cancer from studies of leukemia and hematopoiesis.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
  16. The RARγ Oncogene: An Achilles Heel for Some Cancers.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Acute Myeloid Leukemia withOncoTargets and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Rosa ConservaHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.
Immacolata RedavidHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.
Luisa AnelliHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.
Antonella ZagariaHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.
Giorgina SpecchiaHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.
Francesco AlbanoHematology Section, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoic acid receptor γ (RARγ) belongs to the nuclear receptor superfamily and shares 90% homology with retinoic acid receptor α (RARα) and retinoic acid receptor β (RARβ).

Indexed as

acute myeloid leukemiaacute promyelocytic leukemiagene fusionsprotein fusionsretinoic acid receptor γ

Identifiers

PMID31709264
PMCPMC6822255

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.